199 related articles for article (PubMed ID: 35319461)
1. Dual signaling via interferon and DNA damage response elicits entrapment by giant PML nuclear bodies.
Scherer M; Read C; Neusser G; Kranz C; Kuderna AK; Müller R; Full F; Wörz S; Reichel A; Schilling EM; Walther P; Stamminger T
Elife; 2022 Mar; 11():. PubMed ID: 35319461
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Recombinant Human Cytomegaloviruses Encoding IE1 Mutants L174P and 1-382 Reveals that Viral Targeting of PML Bodies Perturbs both Intrinsic and Innate Immune Responses.
Scherer M; Otto V; Stump JD; Klingl S; Müller R; Reuter N; Muller YA; Sticht H; Stamminger T
J Virol; 2016 Feb; 90(3):1190-205. PubMed ID: 26559840
[TBL] [Abstract][Full Text] [Related]
3. Entrapment of viral capsids in nuclear PML cages is an intrinsic antiviral host defense against varicella-zoster virus.
Reichelt M; Wang L; Sommer M; Perrino J; Nour AM; Sen N; Baiker A; Zerboni L; Arvin AM
PLoS Pathog; 2011 Feb; 7(2):e1001266. PubMed ID: 21304940
[TBL] [Abstract][Full Text] [Related]
4. Promyelocytic Leukemia Protein Potently Restricts Human Cytomegalovirus Infection in Endothelial Cells.
Seitz S; Heusel AT; Stamminger T; Scherer M
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233232
[TBL] [Abstract][Full Text] [Related]
5. An Adenovirus DNA Replication Factor, but Not Incoming Genome Complexes, Targets PML Nuclear Bodies.
Komatsu T; Nagata K; Wodrich H
J Virol; 2016 Feb; 90(3):1657-67. PubMed ID: 26608315
[TBL] [Abstract][Full Text] [Related]
6. Positive role of promyelocytic leukemia protein in type I interferon response and its regulation by human cytomegalovirus.
Kim YE; Ahn JH
PLoS Pathog; 2015 Mar; 11(3):e1004785. PubMed ID: 25812002
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of the Replication of ICP0-Null Mutant Herpes Simplex Virus 1 and pp71-Deficient Human Cytomegalovirus by Epstein-Barr Virus Tegument Protein BNRF1.
Lu Y; Orr A; Everett RD
J Virol; 2016 Nov; 90(21):9664-9673. PubMed ID: 27535048
[TBL] [Abstract][Full Text] [Related]
8. The Human CMV IE1 Protein: An Offender of PML Nuclear Bodies.
Scherer M; Schilling EM; Stamminger T
Adv Anat Embryol Cell Biol; 2017; 223():77-94. PubMed ID: 28528440
[TBL] [Abstract][Full Text] [Related]
9. The Human Cytomegalovirus IE1 Protein Antagonizes PML Nuclear Body-Mediated Intrinsic Immunity via the Inhibition of PML De Novo SUMOylation.
Schilling EM; Scherer M; Reuter N; Schweininger J; Muller YA; Stamminger T
J Virol; 2017 Feb; 91(4):. PubMed ID: 27903803
[TBL] [Abstract][Full Text] [Related]
10. Promyelocytic leukemia (PML) nuclear bodies (NBs) induce latent/quiescent HSV-1 genomes chromatinization through a PML NB/Histone H3.3/H3.3 Chaperone Axis.
Cohen C; Corpet A; Roubille S; Maroui MA; Poccardi N; Rousseau A; Kleijwegt C; Binda O; Texier P; Sawtell N; Labetoulle M; Lomonte P
PLoS Pathog; 2018 Sep; 14(9):e1007313. PubMed ID: 30235352
[TBL] [Abstract][Full Text] [Related]
11. Role and fate of PML nuclear bodies in response to interferon and viral infections.
Regad T; Chelbi-Alix MK
Oncogene; 2001 Oct; 20(49):7274-86. PubMed ID: 11704856
[TBL] [Abstract][Full Text] [Related]
12. Incoming human papillomavirus 16 genome is lost in PML protein-deficient HaCaT keratinocytes.
Bienkowska-Haba M; Luszczek W; Keiffer TR; Guion LGM; DiGiuseppe S; Scott RS; Sapp M
Cell Microbiol; 2017 May; 19(5):. PubMed ID: 27860076
[TBL] [Abstract][Full Text] [Related]
13. Dynamic Response of IFI16 and Promyelocytic Leukemia Nuclear Body Components to Herpes Simplex Virus 1 Infection.
Everett RD
J Virol; 2016 Jan; 90(1):167-79. PubMed ID: 26468536
[TBL] [Abstract][Full Text] [Related]
14. Revisiting promyelocytic leukemia protein targeting by human cytomegalovirus immediate-early protein 1.
Paulus C; Harwardt T; Walter B; Marxreiter A; Zenger M; Reuschel E; Nevels MM
PLoS Pathog; 2020 May; 16(5):e1008537. PubMed ID: 32365141
[TBL] [Abstract][Full Text] [Related]
15. PML Alternative Splice Products Differentially Regulate HAdV Productive Infection.
Mai J; Stubbe M; Hofmann S; Masser S; Dobner T; Boutell C; Groitl P; Schreiner S
Microbiol Spectr; 2022 Aug; 10(4):e0078522. PubMed ID: 35699431
[TBL] [Abstract][Full Text] [Related]
16. Disruption of PML-associated nuclear bodies by IE1 correlates with efficient early stages of viral gene expression and DNA replication in human cytomegalovirus infection.
Ahn JH; Hayward GS
Virology; 2000 Aug; 274(1):39-55. PubMed ID: 10936087
[TBL] [Abstract][Full Text] [Related]
17. A Tale of Usurpation and Subversion: SUMO-Dependent Integrity of Promyelocytic Leukemia Nuclear Bodies at the Crossroad of Infection and Immunity.
Patra U; Müller S
Front Cell Dev Biol; 2021; 9():696234. PubMed ID: 34513832
[TBL] [Abstract][Full Text] [Related]
18. HSV-1 genome subnuclear positioning and associations with host-cell PML-NBs and centromeres regulate LAT locus transcription during latency in neurons.
Catez F; Picard C; Held K; Gross S; Rousseau A; Theil D; Sawtell N; Labetoulle M; Lomonte P
PLoS Pathog; 2012; 8(8):e1002852. PubMed ID: 22912575
[TBL] [Abstract][Full Text] [Related]
19. The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells.
Ahn JH; Hayward GS
J Virol; 1997 Jun; 71(6):4599-613. PubMed ID: 9151854
[TBL] [Abstract][Full Text] [Related]
20. Distinct temporal roles for the promyelocytic leukaemia (PML) protein in the sequential regulation of intracellular host immunity to HSV-1 infection.
Alandijany T; Roberts APE; Conn KL; Loney C; McFarlane S; Orr A; Boutell C
PLoS Pathog; 2018 Jan; 14(1):e1006769. PubMed ID: 29309427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
